Initial outcomes of a single-institution hepatic artery infusion pump program for colorectal liver metastases and intrahepatic cholangiocarcinoma: Safety, feasibility, and circulating tumor DNA tracking
Authors:
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Considerations and barriers to starting a new HAI pump program: an international survey of the HAI Consortium Research NetworkHPB, 2022
- Hepatic arterial infusion pump chemotherapy combined with systemic therapy for patients with advanced colorectal liver metastases: Outcomes in a newly established programJournal of Surgical Oncology, 2022
- Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort studyJournal of Surgical Oncology, 2020
- Questioning Why More Patients With Colorectal Liver Metastases Are Not Referred for MetastasectomyJAMA Surgery, 2020
- Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic CholangiocarcinomaJAMA Oncology, 2020
- Role of Hepatic Artery Infusion Chemotherapy in Treatment of Initially Unresectable Colorectal Liver MetastasesJAMA Surgery, 2019
- Origins, structures, and functions of circulating DNA in oncologyCancer and Metastasis Reviews, 2016
- RECIST 1.1—Update and clarification: From the RECIST committeeEuropean Journal of Cancer, 2016
- Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy aloneCancer, 2015
- A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasoneversus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancerCancer, 1992